Use of disopyramide by arrhythmia specialists after Cardiac Arrhythmia Suppression Trial: patient selection and initial outcome

Am Heart J. 1991 May;121(5):1571-82. doi: 10.1016/0002-8703(91)90178-k.

Authors

E N Prystowsky¹, A L Waldo, J D Fisher

Affiliation

¹ St. Vincent Hospital, Indianapolis, IN.

PMID: 2017999
DOI: 10.1016/0002-8703(91)90178-k

No abstract available

Publication types

Clinical Trial
Research Support, Non-U.S. Gov't

MeSH terms

Arrhythmias, Cardiac / chemically induced
Arrhythmias, Cardiac / drug therapy*
Data Collection / methods
Delayed-Action Preparations
Disopyramide / administration & dosage
Disopyramide / adverse effects
Disopyramide / therapeutic use*
Drug Therapy, Combination
Drug Utilization
Female
Humans
Male
Middle Aged
Practice Patterns, Physicians'*
Randomized Controlled Trials as Topic
Tachycardia / drug therapy
Tachycardia, Supraventricular / drug therapy

Substances

Delayed-Action Preparations
Disopyramide